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Abstract
Background: To describe a case of a 38-year old pregnant woman with an intraoperative diagnosis of placenta 
percreta complicated by central placenta previa. The ultrasound scan did not show signs of any type of abnormal 
placental invasion, just central placenta previa was visualized.
Methods: At 36 weeks of gestation, she underwent an elective cesarean section combined with peripartum 
hysterectomy with bladder wall resection under general anesthesia because of antenatally undiagnosed placenta 
percreta.
Results: The therapy was provided by a multidisciplinary team, and the patient was in relatively good condition. 
Intraoperative blood loss was 2500 mL. A total of 10 units of red blood cells and 3 units of fresh frozen plasma were 
used. Anesthesia time was 2 h and 15 min. The postoperative course was adequate. A live, premature male baby 
(2420 g) was born 8 min after the beginning of the operation with Apgar scores 8 and 7 at 1 minute and 5 minutes.
Conclusion: We want to emphasize that, in spite of the absent typical symptoms and absent typical ultrasound 
signs of placenta percreta, we have to be cautious in the presence of risk factors. If we have a suspicion for adherent 
placenta, an MRI scan should be performed.
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Introduction
Adherent placenta is responsible for 7% to 10% of maternal 
mortality cases worldwide [1]. Its maternal morbidity rate is 9.5% and 
perinatal mortality is 24%. The incidence of abnormal placentation has 
increased from 1 out of 2500 in the 1980s to 1 out of 533 in 2000 [2]. 
The incidence of accreta is 0.1 to 2.3 per 1000 births, and the incidence 
of percreta is 0.03 per 1000 births. The incidence of concomitant 
bladder invasion is approximately 1 in 10,000 births. The incidence 
of peripartum hysterectomy is 0.24 to 1.4 per 1000 births. Adherent 
placenta as a major indication for peripartum hysterectomy has risen 
from 5.4% to 46.5% over the past four decades [3]. The presence of 
a placenta previa, the risk of placenta accreta was 3%, 11%, 40%, 
61%, and 67% for the first, second, third, fourth, and fifth or greater 
repeat cesarean deliveries [4]. Three types of adherent placenta are 
distinguished: placenta accreta is abnormal adherence of the placenta 
only to the myometrium, placenta increta involves invasion of the 
myometrium, while percreta involves invasion through the serous 
surface of the uterus. Placenta percreta can lead to bladder injury, 
bowel injury, life-threatening haemorrhage, amniotic fluid embolism, 
coagulopathy and peripartum hysterectomy. If it is not diagnosed in an 
early stage, it can lead to severe maternal morbidity. The most common 
risk factor for adherent placenta and placenta percreta is cesarean 
section. Besides cesarean delivery further risk factors are reported as 
multiparity, uterine fibroids, embolization of uterine fibroid, advanced 
maternal age, second-trimester serum levels of alpha-fetoprotein (AFP) 
and free beta-hCG greater than 2.5 multiples of the median without any 
anatomical malformation, hypertensive disorders, or smoking [5-7], 
any condition resulting in myometrial tissue damage such as previous 
myomectomy, endometritis, endometrial defects due to curettage 
resulting in Asherman syndrome [8], thermal ablation [9], and uterine 
artery embolization [10]. Such abnormalities include placenta previa as 
well as placenta accreta. We present the case of a 38-year-old woman 
with suspicion of placenta accreta prenatally and intraoperatively 
diagnosed with anterior placenta percreta complicated by placenta 
previa. Placenta percreta can be associated with extreme haemorrhage, 
thus, preoperative planning is advised.
Materials and methods
The diagnosis of adherent placenta is established by 
ultrasonography and occasionally by magnetic resonance imaging 
(MRI). Ultrasonography findings of accreta and percreta include loss of 
myometrial interface, retroplacental ”clear space”, reduced myometrial 
thickness, intraplacental lacunae, turbulent blood flow through the 
lacunae in Doppler ultrasonography [11,12], and an irregular bladder 
wall. Placental bulging or invasion into the bladder is also frequently 
seen. The presence of lacunae within the placenta at 15-20 weeks of 
gestation has been shown to be the most predictive sign of placenta 
accrete in the ultrasonogram, with a sensitivity of 79% and a positive 
predictive value of 92% [13]. These lacunae may result in a placenta 
having a “moth-eaten” or “Swiss cheese” appearance. MRI may help 
in diagnosing invasive placentation, mainly in those conditions 
when the ultrasound findings are not conclusive enough to assess the 
degree of the invasion. It is more accurate in diagnosing a posterior 
placenta, placenta percreta with or without placenta previa and for 
obese patients. MRI is more costly and accurate than ultrasonography 
in identifying adherent placenta [14]. Features of placenta percreta in 
non-enhanced MRI include loss of myometrium overlying the placenta, 
placental tissue extending to the bladder, heterogeneous signal intensity 
in the placenta, focal areas of uterine bulging, and loss of interface with 
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adjacent organs [15]. The use of gadolinium contrast is controversial 
because of the risk of possible fetal effects. It may penetrate through the 
placenta. It enables MRI to more clearly delineate the outer placental 
surface relative to the myometrium, and differentiate between the 
heterogeneous vascular signals within the placenta from those caused 
by maternal blood vessels. A multidisciplinary approach by a team 
of experienced obstetricians, anaesthetists, nurses, interventional 
radiologists, neonatologists, urologists and blood bank officers ensures 
the best outcomes [16]. It is fundamental that obstetricians are aware of 
the risk factors and diagnostic modalities for placenta accreta because of 
its potential emergent nature and the associated risk of life-threatening 
haemorrhage. Women with any type of adherent placenta should be 
treated at a tertiary perinatal care center. Optimum management of 
placenta percreta requires early detection and a planned cesarean 
hysterectomy, ideally at about 35-36 weeks [17]. Occasionally, a subtotal 
hysterectomy can be safely performed, but persistent bleeding from 
the cervix may preclude this approach and make total hysterectomy 
necessary. Hysterectomy has been the gold standard in management, 
but conservative management can be used in selected cases [18]. 
Conservative interventions are recommended before radical procedure 
in order to minimize surgical complications and preserve fertility. The 
conservative options for peripartum hysterectomy included uterotonic 
drugs, external compression with uterine sutures (B-Lynch, Hayman, 
Cho), intrauterine packing (Bakri balloon), Triple-P procedure, and 
selective devascularization by ligation or embolization of the uterine 
artery [19-21]. Identifying the extent of infiltration by the placenta and 
performing preoperative placement of bilateral iliac artery or aorta 
balloon catheters to be inflated after delivery can considerably reduce 
the bleeding. Preoperative placement of ureteral stents can help identify 
the ureters, allowing more rapid completion of the hysterectomy [22]. 
Retaining the placenta in situ at cesarean section for placenta percreta 
and awaiting placental reabsorption is widely practiced; however, 
there is limited evidence on the efficacy and complications of this 
strategy: high rate of sepsis, postoperative haemorrhage, and secondary 
hysterectomy. Methotrexate has been widely used to increase the rate of 
placental reabsorption.
Results
A 38-year-old woman was admitted to our clinic for prenatal 
observation, and her second elective cesarean section at 34 weeks’ 
of gestation, and for her central placenta previa complicated by 
placenta accreta. She had a history of nine previous pregnancies, 
two terminations, seven deliveries and one cesarean section due to 
intrauterine fetal distress. She underwent ultrasonography during 
pregnancy to rule out other types of adherent placenta such as placenta 
increta and percreta, but the scan did not show signs of any other 
type of abnormal placental invasion, so she did not undergo MRI. An 
ultrasound examination revealed a single intra-uterine live male fetus 
in normal presentation and central placenta previa with typical signs 
(Figures 1 and 2). She suffered from obesity, her pregestational body 
mass index was 31 kg/m2, her weight gain was 4 kg during pregnancy, 
and second-trimester serum level of AFP value was 2.1 multiples 
of median. She did not smoke either before or during pregnancy. 
No haematuria was detected. Her blood group was “A” Rh negative. 
On admission, the patient was hemodynamically stable. There were 
no uterine contractions and she did not have any vaginal bleeding. 
Symptoms such as haematuria occur in approximately 25% of the cases. 
The fetal heart rate was 140 beats per minute, and CTG was evaluated 
by reactive result. We had to be cautious during the vaginal examination 
because of the higher chance of bleeding. The cervix was closed 
(3.1.0.0.). On admission, the patient was given antenatal corticosteroid 
(4 times 6 mg Dexa Ratiopharm in 12 hours). Given the findings, a 
planned cesarean section was performed at 36 weeks of gestation under 
general anesthesia in the presence of experienced, skilled obstetricians, 
anaesthetists, neonatologists, urologists and nurses. General anesthesia 
was chosen to get better muscle relaxation because of procedure’s 
length and a better hemodynamic stability in case of a possible massive 
haemorrhage. During general anesthesia, propofol, fentanyl, atropin, 
esmeron, stigmosan were administered, and anesthesia was maintained 
by using propofol and fentanyl. After opening the abdominal wall, 
intra-abdominal inspection revealed placental tissue on the external 
surface of the uterus, accordingly in the previous cesarean section’s scar. 
On the border of the active and passive parts of the uterus, a transversal 
cut was performed. We extracted a live, premature male baby (2420 g) 
8 min after the beginning of the operation, with Apgar scores 8 and 7 at 
1 minute and 5 minutes. At birth, the premature infant required extra 
oxygen through ambu-mask for 30 sec, after that O2 saturation was 95%, 
Figure 1: Ultrasound investigation of the placenta at 20 weeks of gestation (Color 
Doppler-mode). There is not increased vascularity and ‘alising’ at retroplacental 
zone. The evaluation of placental vessel architecture with Doppler imaging may 
help differentiate. It should be noted that placenta accretes have been reported 
with absent multiple vascular lacunaes [25].
Figure 2: Ultrasound investigation of the placenta at 20 weeks of gestation 
(B-mode). Visualization of prominent vessels or lakes within the placenta or 
myometrium is missing. Normal-like hypoechoic retroplacental zone between 
the placenta and uterine wall.
Citation: Malnar A, Suranyi A, Jako M, Nemeth G (2016) Intraoperative Surgical Treatment of Undiagnosed Placenta Percreta. J Clin Case Rep 6: 
910. doi: 10.4172/2165-7920.1000910
Page 3 of 4
Volume 6 • Issue 12 • 1000910J Clin Case Rep, an open access journalISSN: 2165-7920
infection. In hysterectomy, the bladder injury was higher than in 
other procedures. Following local resection, there were no significant 
complications, but due to the infrequency of placenta previa, it is often 
not possible to acquire proficiency in the local resection technique. 
Hysterectomy was chosen in the majority of the cases included in 
this review. The estimated blood loss was the least when endovascular 
balloon occlusion of the common iliac artery or the aorta was used [23]. 
Nelson and O’Brien have reported that placing an intrauterine Bakri 
balloon in conjunction with the B-Lynch uterine compression suture 
defined as “uterine sandwich” was successful in treating uterine atony. 
Nowadays evidence suggest that in cases of morbidly adherent 
placenta (MAP) leaving placenta and either considering embolization 
or returning at later time for hysterectomy is a safer method [23]. 
Despite the early and accurate prenatal diagnosis, hysterectomy 
remains the most common surgical procedure in cases of peripartum 
hysterectomy for placenta previa accreta. According to our opinion, the 
decision whether to choose hysterectomy electively, leave the placenta 
in situ or perform local resection depends on the available expertise in 
each medical center. We wish to emphasize that, in spite of the absent 
typical symptoms and absent typical ultrasound signs of placenta 
percreta, we should be vigilant about the presence of risk factors. If we 
have a suspicion of adherent placenta, MRI should be performed.
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umbilical cord blood pH value was 7.35, Hematocrit was 42%, blood 
glucose value was 3.6 mmol/L, temperature was 36.6°C, pulse was 134/
min, urinary bacteriology test was positive to Klebsiella pneumoniae. 
As antibiotic therapy, Clavulan acid was administered. In the adaptation 
phase, she had tachypnea, but 6 hours later it disappeared. She tolerated 
the feeding. The surgeon could not extract the whole placenta tissue 
manually. A part of the placenta which was placed on the anterior wall 
of the uterus near the neighbouring bladder was completely embedded 
in the myometrium and serosa reaching the wall of bladder. Hence 
the obstetrician was unable to separate the entire placenta because it 
was penetrating the uterus and it was eroding the posterior wall of the 
bladder. The urologist performed a partial cystectomy of the posterior 
wall of the bladder to separate the placenta, after which hysterectomy 
was undertaken with repair of the wall of the bladder leaving back an 
epicystostomy catheter. Intra-operative bleeding was 2500 mL, and 
hemodynamic instability developed. The patient was managed with 
vasopressors, blood products, and fluid replacement: exacyl, ephedrine, 
hemocomplettan, oxytocin, and Standacillin. Transfusion was initiated. 
A total of 10 units of red blood cells and 3 units of fresh frozen plasma were 
administered. Anesthesia time was 2 h and 15 min. The postoperative 
recruitment was adequate. The urine catheter was removed on the 10th 
and epicystostomy catheter on the 3rd postoperative day. The uterus was 
sent to the pathology institute for examination. Histology confirmed a 
morbidly adherent placenta percreta involving the uterine serosa. She 
was discharged on the 11th postoperative day in good health condition. 
She had satisfactory Hemostasis: the blood pressure was 115/75 mmHg, 
and the pulse was 83 per minute.
Discussion
Abnormal placental adherence can be classified into three distinct 
conditions: placenta accreta, increta and percreta. Placenta percreta 
is the most severe of the abnormally invasive placentas, and it is 
associated with a significantly higher morbidity and mortality. Their 
incidence has increased parallel with the increasing rate of cesarean 
deliveries. Recognition at an early stage of the adherent placenta 
and the multidisciplinary team work are essential in the light of the 
treatment and the clinical outcome of the patients with placenta 
percreta. The diagnosis of placenta percreta before the delivery may 
give us a chance to plan a multidisciplinary attempt to reduce potential 
maternal or neonatal morbidity and mortality. However, several cases 
of placenta accreta, increta and percreta are not diagnosed antenatally, 
despite the presence of the risk factors. Obstetricians should be vigilant 
in the diagnosis of adherent placenta, even if ultrasonography results 
are normal, just like in our case. Ultrasonography is a useful method in 
screening for placenta previa and adherent placenta. In cases, if there 
is a suspicion of abnormal placental adherence and no typical signs of 
adherent placenta are seen, MRI should be used to identify placental 
location accurately, regardless of the ultrasonography findings. The risk 
factors of clinical history should be highlighted: obesity, blood group, 
AFP, and multiparity. In our case, there were no typical clinical features, 
but AFP was elevated and BMI was above the normal value.
Regarding placenta percreta, different kinds of surgical strategies 
exist, such as local resection, leaving the placenta in situ (when the 
aim is to preserve fertility) and hysterectomy. Nowadays, conservative 
interventions are recommended before radical procedure in order to 
minimize surgical complications. These vascular interventions are 
balloon occlusion and/or embolization of the vessels supplying the 
placenta and the uterus [23]. A study has compared these procedures 
[23]. The most frequent complications when the placenta was left in 
situ were secondary hysterectomy, postoperative haemorrhage and 
Citation: Malnar A, Suranyi A, Jako M, Nemeth G (2016) Intraoperative Surgical Treatment of Undiagnosed Placenta Percreta. J Clin Case Rep 6: 
910. doi: 10.4172/2165-7920.1000910
Page 4 of 4
Volume 6 • Issue 12 • 1000910J Clin Case Rep, an open access journalISSN: 2165-7920
15. Maldjian C, Adam R, Pelosi M, Pelosi M, Rudelli R, et al. (1999) MRI appearance 
of placenta percreta and accreta. Magn Reson Imaging 17: 965-971.
16. Parva M, Chamchad D, Keegan J, Gerson A, Horrow J (2010) Placenta 
percreta with invasion of the bladder wall: management with a multi-disciplinary 
approach. J Clin Anesth 22: 209-212.
17. Sivasankar C (2012) Perioperative management of undiagnosed placenta percreta: 
case report and management strategies. Int J Womens Health 4: 451-454.
18. Courbière B, Bretelle F, Porcu G, Gamerre M, Blanc B (2003) Conservative 
treatment of placenta accreta. J Gynecol Obstet Biol Reprod 32: 549-554.
19. Flood KM, Said S, Geary M, Robson M, Fitzpatrick MC, et al. (2009) Changing 
trends in peripartum hysterectomy over the last 4 decades. Am J of Obstet 
Gynecol 200: 632.e1-e6.
20. Cho JH, Jun HS, Lee CN (2000) Hemostatic suturing technique for uterine 
bleeding during cesarean delivery. Obstet Gynecol 96: 129-131.
21. Eller AG, Porter TF, Soisson P, Silver RM (2009) Optimal management 
strategies for placenta accreta. BJOG 116: 648-654.
22. Palacios Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid S (2004) Anterior 
placenta percreta: surgical approach, hemostasis and uterine repair. Acta 
Obstet Gynecol Scand 83: 738-744.
23. Caroline C, Lars L, Jens LR (2014) Management of placenta percreta: A review 
of published cases. Acta Obstet Gynecol Scand 93: 138-143.
24. Lim BH, Palacios-Jaraquemada JM. The morbidity adherent placenta- a 
continuing diagnostic and management challange. BJOG 2015;122(12):1673.
25. Baugham WC, Corteville JE Shah RR. Placenta accreta: spectrum of US and 
MR imaging findings. Radiograhics 2008;28:1905-1916.
OMICS International: Open Access Publication Benefits & 
Features
Unique features:
• Increased global visibility of articles through worldwide distribution and indexing
• Showcasing recent research output in a timely and updated manner
• Special issues on the current trends of scientific research
Special features:
• 700+ Open Access Journals
• 50,000+ editorial team
• Indexing at major indexing services
• Rapid review process
• Quality and quick editorial, review and publication processing
• Indexing at major indexing services
• Sharing Option: Social Networking Enabled
• Authors, Reviewers and Editors rewarded with online Scientific Credits
• Better discount for your subsequent articles
Submit your manuscript at: http://www.omicsonline.org/submission//
Citation: Malnar A, Suranyi A, Jako M, Nemeth G (2016) Intraoperative 
Surgical Treatment of Undiagnosed Placenta Percreta. J Clin Case Rep 6: 910. 
doi: 10.4172/2165-7920.1000910
